Literature DB >> 3147004

Anaphylactic reactions to cinoxacin.

B H Stricker1, G Slagboom, R Demaeseneer, V Slootmaekers, I Thijs, S Olsson.   

Abstract

During 1981 to mid-1988 three cases of anaphylactic shock after treatment with the quinolone derivative cinoxacin were reviewed by the Netherlands Centre for Monitoring of Adverse Reactions to Drugs and 17 cases of an anaphylactic type of reaction notified to the World Health Organisation Collaborating Centre for International Drug Monitoring. In five out of six patients for whom data were available the reaction began shortly after taking a single capsule of a second or next course of treatment. Cinoxacin is related to nalidixic acid, and one patient previously treated with that agent subsequently had an anaphylactoid reaction to cinoxacin and later developed a skin reaction to nalidixic acid. There were no deaths, and patients treated as an emergency with plasma expanders or with adrenaline and corticosteroids generally recovered promptly and uneventfully. In view of the potentially fatal consequences of anaphylactic reactions to cinoxacin and other quinolones doctors should take care when prescribing these drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147004      PMCID: PMC1835179          DOI: 10.1136/bmj.297.6661.1434

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  3 in total

1.  Anaphylaxis caused by pipemidic acid.

Authors:  D Gerber
Journal:  S Afr Med J       Date:  1985-06-22

Review 2.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 3.  Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.

Authors:  T S Sisca; R C Heel; J A Romankiewicz
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

  3 in total
  4 in total

1.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.

Authors:  S Olsson
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

Review 3.  Clinical features and management of adverse effects of quinolone antibacterials.

Authors:  J H Paton; D S Reeves
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

4.  Post-marketing surveillance of quinolones 1988-1990.

Authors:  P G Davey; T McDonald; G Lindsay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.